As PSP is also mediated by tau pathology, we hypothesize that diabetes mellitus could act as a modifiable risk factor and etiologic factor for PSP: patients with diabetes mellitus have reduced brain glucose levels, which leads to less oxidative phosphorylation, increased levels of reactive oxygen species, contributing to tau pathology and a higher risk of PSP. The gene discussed is MAPT; the disease is diabetes mellitus.